ESSENCA Trademark

Trademark Overview


On Monday, December 2, 2019, a trademark application was filed for ESSENCA with the United States Patent and Trademark Office. The USPTO has given the ESSENCA trademark a serial number of 88711676. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, December 12, 2022. This trademark is owned by Essenlix Corporation. The ESSENCA trademark is filed in the Chemical Products, Pharmaceutical Products, Medical Instrument Products, and Medical & Beauty Services & Agricultural Services categories with the following description:

Medical diagnostic reagents and assays for testing of body fluids; Medical diagnostic reagents and assays for testing cells, proteins, small molecules, nucleotides, and nucleic acids; Medical diagnostic reagents; Diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection, namely, cancer, blood abnormalities, immune diseases, neurological diseases, cardiovascular diseases, infectious diseases, viral diseases, and genetic diseases; Diagnostic biomarker reagents for medical purposes; Biological and chemical testing kits for personal wellness in the nature of diagnostic test kits consisting primarily of medical diagnostic reagents and assays for testing of bodily fluids and substances examined in bodily fluids, namely, cells, proteins, small molecules, nucleotides, and nucleic acids for use in disease detection, namely, cancer, blood abnormalities, immune diseases, neurological diseases, cardiovascular diseases, infectious ...

Assays for research purposes; Biological and chemical reagents used for non-medical research and laboratory purposes, namely, in vitro and in vivo scientific use, the testing of bodily fluids, and the detecting and analyzing of cells, proteins, small molecules, and nucleotides; Biological and chemical test kits comprised of biological, chemical, and diagnostic reagents for the detection and identification of nucleic acids, namely, DNA and RNA in a sample, for laboratory and research use

Medical services; Medical assistance; Medical consultations; Medical counseling; Medical information; Nutrition counseling; Healthcare services in the field of digital healthcare services, namely, the diagnosis of diseases, namely, cancer, blood abnormalities, immune diseases, neurological diseases, cardiovascular diseases, infectious diseases, viral diseases, and genetic diseases; Diagnostic services, namely, medical testing for diagnostic purposes; Wellness services, namely, providing wellness information in the nature of providing information in the fields of health and wellness; Medical testing services for the detection and identification of cells, proteins, small molecules, and nucleic acids in a sample in the nature of medical testing for diagnostic or treatment purposes; Health monitoring services, namely, monitoring of data indicative of the health or condition of an individual or group of individuals for medical diagnosis and treatment purposes in the fields of cancer, blood ...

Medical diagnostic apparatus for testing cells, tissue, biomolecules, proteins, small molecules, and nucleotides; Medical devices for obtaining bodily fluid samples; Medical diagnostic instruments for the analysis of bodily fluids; Medical apparatus for diagnostic use, namely, medical apparatus for diagnostic testing of health conditions, diseases, or abnormalities, namely, cancer, blood abnormalities, immune diseases, neurological diseases, cardiovascular diseases, infectious diseases, viral diseases, genetic diseases, and endocrine diseases, and other tissue-based diagnostic testing, cytology, and cell based testing; Medical apparatus, devices, and instruments for wellness testing, health condition testing, and healthcare testing, namely, point-of-care diagnostic devices, at-home diagnostic devices, and health monitoring devices that detect health conditions and diseases in the nature of cancer, blood abnormalities, immune diseases, neurological diseases, cardiovascular diseases, inf...
essenca

General Information


Serial Number88711676
Word MarkESSENCA
Filing DateMonday, December 2, 2019
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, December 12, 2022
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 15, 2020

Trademark Statements


Goods and ServicesMedical diagnostic reagents and assays for testing of body fluids; Medical diagnostic reagents and assays for testing cells, proteins, small molecules, nucleotides, and nucleic acids; Medical diagnostic reagents; Diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection, namely, cancer, blood abnormalities, immune diseases, neurological diseases, cardiovascular diseases, infectious diseases, viral diseases, and genetic diseases; Diagnostic biomarker reagents for medical purposes; Biological and chemical testing kits for personal wellness in the nature of diagnostic test kits consisting primarily of medical diagnostic reagents and assays for testing of bodily fluids and substances examined in bodily fluids, namely, cells, proteins, small molecules, nucleotides, and nucleic acids for use in disease detection, namely, cancer, blood abnormalities, immune diseases, neurological diseases, cardiovascular diseases, infectious diseases, viral diseases, and genetic diseases; Medicines for medical and veterinary purposes for cancers, blood abnormalities, immune disease, neurological diseases, cardiovascular diseases, infectious diseases, viral diseases, and genetic diseases; Medical diagnostic reagents and assays for testing bodily fluids for the prevention of disease in the nature of cancer, blood abnormalities, immune diseases, neurological diseases, cardiovascular diseases, infectious diseases, viral diseases and genetic diseases; Medical diagnostic reagents and assays for testing bodily fluids for monitoring and testing illnesses and disorders in the nature of cancer, blood abnormalities, immune diseases, neurological diseases, cardiovascular diseases, infectious diseases, viral diseases, and genetic diseases
Pseudo MarkESSENCE
Goods and ServicesAssays for research purposes; Biological and chemical reagents used for non-medical research and laboratory purposes, namely, in vitro and in vivo scientific use, the testing of bodily fluids, and the detecting and analyzing of cells, proteins, small molecules, and nucleotides; Biological and chemical test kits comprised of biological, chemical, and diagnostic reagents for the detection and identification of nucleic acids, namely, DNA and RNA in a sample, for laboratory and research use
Translation of Words in MarkThe wording "ESSENCA" has no meaning in a foreign language.
Goods and ServicesMedical services; Medical assistance; Medical consultations; Medical counseling; Medical information; Nutrition counseling; Healthcare services in the field of digital healthcare services, namely, the diagnosis of diseases, namely, cancer, blood abnormalities, immune diseases, neurological diseases, cardiovascular diseases, infectious diseases, viral diseases, and genetic diseases; Diagnostic services, namely, medical testing for diagnostic purposes; Wellness services, namely, providing wellness information in the nature of providing information in the fields of health and wellness; Medical testing services for the detection and identification of cells, proteins, small molecules, and nucleic acids in a sample in the nature of medical testing for diagnostic or treatment purposes; Health monitoring services, namely, monitoring of data indicative of the health or condition of an individual or group of individuals for medical diagnosis and treatment purposes in the fields of cancer, blood abnormalities, immune diseases, neurological diseases, cardiovascular diseases, infectious diseases, viral diseases, and genetic diseases; Disease prevention services, namely, medical screening and testing services for preventing diseases in the fields of cancer, blood abnormalities, immune diseases, neurological diseases, cardiovascular diseases, infectious diseases, viral diseases, and genetic diseases; Medical and healthcare services for monitoring and testing illnesses and disorders in the nature of cancer, blood abnormalities, immune diseases, neurological diseases, cardiovascular diseases, infectious diseases, viral diseases, and genetic diseases
Goods and ServicesMedical diagnostic apparatus for testing cells, tissue, biomolecules, proteins, small molecules, and nucleotides; Medical devices for obtaining bodily fluid samples; Medical diagnostic instruments for the analysis of bodily fluids; Medical apparatus for diagnostic use, namely, medical apparatus for diagnostic testing of health conditions, diseases, or abnormalities, namely, cancer, blood abnormalities, immune diseases, neurological diseases, cardiovascular diseases, infectious diseases, viral diseases, genetic diseases, and endocrine diseases, and other tissue-based diagnostic testing, cytology, and cell based testing; Medical apparatus, devices, and instruments for wellness testing, health condition testing, and healthcare testing, namely, point-of-care diagnostic devices, at-home diagnostic devices, and health monitoring devices that detect health conditions and diseases in the nature of cancer, blood abnormalities, immune diseases, neurological diseases, cardiovascular diseases, infectious diseases, viral diseases and genetic diseases; Medical apparatus, devices, and instruments for the detection and identification of nucleic acids, namely, DNA and RNA in a sample, in the nature of apparatus for DNA and RNA testing for medical purposes; Medical diagnostic instruments for the analysis of body fluids in the nature of biological and chemical test kits for the detection and identification of nucleic acids, namely, DNA and RNA in a sample; Medical diagnostic apparatus for testing cells, tissue, biomolecules, proteins, small molecules, nucleic acids, and nucleotides for the prevention of disease in the nature of cancer, blood abnormalities, immune diseases, neurological diseases, cardiovascular diseases, infectious diseases, viral diseases and genetic diseases

Classification Information


International Class001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes001, 005, 006, 010, 026, 046
Class Status Code6 - Active
Class Status DateFriday, December 6, 2019
Primary Code001
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, December 6, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateFriday, December 6, 2019
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, December 6, 2019
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameEssenlix Corporation
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressMonmouth Junction, NJ 08852

Party NameEssenlix Corporation
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressMonmouth Junction, NJ 08852

Trademark Events


Event DateEvent Description
Monday, December 12, 2022ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, December 12, 2022ABANDONMENT - NO USE STATEMENT FILED
Thursday, May 26, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, May 25, 2022SOU EXTENSION 3 GRANTED
Tuesday, May 10, 2022SOU EXTENSION 3 FILED
Tuesday, May 24, 2022NOTICE OF REVIVAL - E-MAILED
Monday, May 23, 2022SOU EXTENSION RECEIVED WITH TEAS PETITION
Monday, May 23, 2022PETITION TO REVIVE-GRANTED
Monday, May 23, 2022TEAS PETITION TO REVIVE RECEIVED
Friday, January 14, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, January 13, 2022SOU EXTENSION 2 GRANTED
Wednesday, November 10, 2021SOU EXTENSION 2 FILED
Tuesday, January 11, 2022CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, November 16, 2021NOTICE OF REVIVAL - E-MAILED
Tuesday, November 16, 2021SOU EXTENSION RECEIVED WITH TEAS PETITION
Tuesday, November 16, 2021PETITION TO REVIVE-GRANTED
Tuesday, November 16, 2021TEAS PETITION TO REVIVE RECEIVED
Tuesday, May 11, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, May 7, 2021SOU EXTENSION 1 GRANTED
Friday, May 7, 2021SOU EXTENSION 1 FILED
Friday, May 7, 2021SOU TEAS EXTENSION RECEIVED
Tuesday, November 10, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, September 15, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 15, 2020PUBLISHED FOR OPPOSITION
Wednesday, August 26, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, August 13, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, August 11, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, August 11, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Sunday, August 9, 2020ASSIGNED TO LIE
Wednesday, July 22, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, January 22, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, January 22, 2020NON-FINAL ACTION E-MAILED
Wednesday, January 22, 2020NON-FINAL ACTION WRITTEN
Tuesday, January 14, 2020ASSIGNED TO EXAMINER
Friday, December 6, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, December 5, 2019NEW APPLICATION ENTERED